Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators

Abstract Background Direct-acting antivirals (DAAs) are increasingly accessible to patients with hepatitis C (HCV) worldwide and are being introduced through national health systems in sub-Saharan Africa. DAAs are highly efficacious when tested in controlled trials, yet patients treated outside of s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Janvier Serumondo, Michael J. Penkunas, Julienne Niyikora, Alida Ngwije, Athanase Kiromera, Emmanuel Musabeyezu, Justine Umutesi, Sabine Umuraza, Gentille Musengimana, Sabin Nsanzimana
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-06-01
Edice:BMC Public Health
Témata:
Hepatitis C
Direct-acting antivirals
Qualitative
Sub-Saharan Africa
Rwanda
On-line přístup:http://link.springer.com/article/10.1186/s12889-020-09000-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky